The a2 Milk Company
New Zealand public dairy company
The a2 Milk Company
| Type | Public |
|---|---|
| Traded as | ASX: A2M, NZX: ATM |
| Key people | David Hearn (Chairman), David Bortolussi (CEO) |
| Industry | Dairy |
| Products | Milk, Infant formula, Cream, Yogurt |
| Revenue | 
NZ$1.73 billion (2020) |
| Operating income |
NZ$549.7 million (2020) |
| Net income |
NZ$385.8 million (2020) |
| Employees | 300+ (2020) |
| Website | [thea2milkcompany.com Official website] |
The a2 Milk Company is a New Zealand-based public dairy company that specializes in the production and marketing of A2 protein-only milk and related products. The company was founded in 2000 by Corran McLachlan, a scientist who discovered that proteins in milk could be categorized into A1 and A2 types. The a2 Milk Company focuses on producing milk that contains only the A2 type of beta-casein protein, which is believed to be easier to digest for some people.
History[edit]
The a2 Milk Company was established in 2000 by Corran McLachlan and Howard Paterson. The company initially focused on the New Zealand market but has since expanded its operations internationally, including in Australia, China, and the United States. The company was listed on the New Zealand Exchange (NZX) in 2004 and later on the Australian Securities Exchange (ASX) in 2015.
Products[edit]
The a2 Milk Company offers a range of dairy products, including:
These products are marketed as being easier to digest for people who may experience discomfort from consuming regular milk that contains both A1 and A2 proteins.
Market Expansion[edit]
The a2 Milk Company has seen significant growth in recent years, particularly in the Chinese market, where there is a high demand for premium infant formula. The company has also expanded its presence in the United States, where it has partnered with major retailers to distribute its products.
Controversies[edit]
The a2 Milk Company has faced criticism and legal challenges from competitors and regulatory bodies. Some of these controversies revolve around the health claims made about A2 protein-only milk and its purported benefits over regular milk.
See also[edit]
References[edit]
External links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
